FMII
TVTX icon

Farmers & Merchants Investments Inc’s Travere Therapeutics TVTX Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-143
Closed -$3K – 1754
2022
Q2 		$3K Hold
143
– – ﹤0.01% 907
2022
Q1 		$4K Hold
143
– – ﹤0.01% 906
2021
Q4 		$4K Hold
143
– – ﹤0.01% 919
2021
Q3 		$3K Buy
+143
New +$2.63K ﹤0.01% 904

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Farmers & Merchants Investments Inc's TVTX Position: Q3 2022 in Review

Farmers & Merchants Investments Inc sold out of Travere Therapeutics (TVTX) in Q3 2022, closing a stake of 143 shares — an estimated $3K sold.

Farmers & Merchants Investments Inc first reported a position in TVTX in Q3 2021 and held it in 4 quarters. The position peaked at $4K in Q1 2022. 171 funds tracked by Wall St. Rank hold TVTX as of Q3 2022.

  • Farmers & Merchants Investments Inc reported no remaining Travere Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 143 Travere Therapeutics shares in Q3 2022, an estimated $3K.
  • Farmers & Merchants Investments Inc first reported a position in Travere Therapeutics in Q3 2021 and held it in 4 quarters.
  • Farmers & Merchants Investments Inc's Travere Therapeutics position peaked at $4K in Q1 2022.
  • 171 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2022.

Based on Farmers & Merchants Investments Inc's 13F filing for Q3 2022, filed 31 Oct 2022.